ACADIA Pharmaceuticals to Announce Third Quarter 2014 Financial Results on November 10, 2014

ACADIA to Host Conference Call and Webcast on Monday, November 10, 2014, at 5:00 p.m. Eastern Time

SAN DIEGO--()--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2014 on Monday, November 10, 2014, after the U.S. financial markets close. ACADIA's management will host a conference call and webcast on Monday, November 10, 2014, at 5:00 p.m. Eastern Time to discuss ACADIA’s financial results and development programs.

The conference call may be accessed by dialing 866-318-8615 for participants in the United States or Canada and 617-399-5134 for international callers (reference passcode 86826740). A telephone replay of the conference call may be accessed through November 24, 2014 by dialing 888-286-8010 for callers in the United States or Canada and 617-801-6888 for international callers (reference passcode 62605343). The conference call also will be webcast live on ACADIA’s website, www.acadia-pharm.com under the investors section and will be archived there until November 24, 2014.

Contacts

ACADIA Pharmaceuticals Inc.
Steve Davis, Executive Vice President,
Chief Financial Officer and Chief Business Officer
Lisa Barthelemy, Director of Investor Relations
858-558-2871

Contacts

ACADIA Pharmaceuticals Inc.
Steve Davis, Executive Vice President,
Chief Financial Officer and Chief Business Officer
Lisa Barthelemy, Director of Investor Relations
858-558-2871